NAMS
NewAmsterdam Pharma Co N.V.
$36.99
+2.09 (+5.99%)
At close · Jul 7
Market Cap
$4.32B
Shares
116,903,979
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$36.99
Open$35.36
Day$34.27–37.37
52W$19.22–42.21
Avg vol 30d1.2M
Short int9.2M · 7.8% float · 7.3d
Short vol44%
Last earningsMay 7, 2026
DataFeb 2021–Jul 2026
Filing10-Q · May 7
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 16.1 · calm
Equity put/call 0.69
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+10%
above
Price vs 50-day avg
+12%
above
RSI (14)
69
neutral
MACD trend
Positive
52-week position
77%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+17%
trailing
6-month return
+13%
trailing
YTD return
+5%
this year
Relative strength
+6%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $33 › 200d $34 — 200d above 50d
Institutional flow
Distributing
4 of 171 funds reported for Jun 30 · net -178 sh shares · +1 new
Insider flow
Distributing
Net -$2.3M over 90 days · 100% sells
Short interest
Rising
7.85% of float · ▲ +13.2% MoM · 7.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
171 holders — mid 3-yr range
Squeeze score
67
elevated · 0–100
Fundamentals
Revenue growth
−51%
Y/Y
EPS growth
+33%
Y/Y
Balance sheet
$490.0M
net cash
Quant / Vol
risk profile
Volatility
57%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
5.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 6, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 7, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+10%
Bullish
Price vs 50-day avg
+12%
Bullish
RSI (14)
69
Neutral
MACD trend
Positive
Bullish
52-week position
77%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $33 › 200d $34 — 200d above 50d
Institutional flow
Distributing
4 of 171 funds reported for Jun 30 · net -178 sh shares · +1 new
Insider flow
Distributing
Net -$2.3M over 90 days · 100% sells
Short interest
Rising
7.85% of float · ▲ +13.2% MoM · 7.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
171 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $19
Now $37 · 77%
52-wk high $42
vs 200-day avg +10%
vs 50-day avg +12%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Cash, cash equivalents and marketable securities | $728.9M | FY2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NAMS
this stock
NewAmsterdam Pharma Co N.V.
|
$4.32B | +5.4% | -50.6% | — | 7.8% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NAMS | +9.2% | +17.4% | +13.2% | +9.2% | +5.4% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +8.3% | +16.0% | +5.6% | +9.0% | -4.2% |